Acne vulgaris on the back of a healthy 13-year-old boy A dermatologist explores dealing with increasing bacterial resistance and selecting the treatment that minimizes irritation and other skin ...

Acne vulgaris is driven by Cutibacterium acnes, sebaceous activity, and innate immune activation, leading to inflammation, scarring, and reduced quality of life. Although standard topical and systemic ...

The treatment of acne ( Table I) [1,2,3,4,5,6] is based upon its severity (mild, moderate, severe) and the type(s) of lesion(s) present (noninflammatory, inflammatory, mixed). In general, the ...

Credit: Getty Images The American Academy of Dermatology has issued updated guidelines on the clinical management of acne vulgaris. The American Academy of Dermatology (AAD) has issued updated ...

Acne is one of the most common skin conditions seen in general practice. Acne vulgaris—the most prevalent form—affects more than 80% of teenagers and young adults (in some countries, it may be as many ...

The first FDA-approved acne drug with a first-in-class mechanism of action in nearly 40 years launched in the United States in November 2021 after being approved in August 2020. The first-in-class ...

Trifarotene plus skin care is beneficial for patients with moderate acne vulgaris (AV) and acne-induced hyperpigmentation (AIH), according to a study published online April 29 in the International ...

Please provide your email address to receive an email when new articles are posted on . Acne vulgaris may be driven by underlying systemic, immune-inflammatory pathways. Addressing those underlying ...

Please provide your email address to receive an email when new articles are posted on . Denifanstat, a fatty acid synthase inhibitor, was effective in the treatment of moderate to severe acne vulgaris ...